Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin
Clinical trial NCT05118724 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05118724
- Sponsor
- AIO-Studien-gGmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2027-04-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.